How to buy Isoray stock

Isoray, Inc is a medical instruments & supplies business based in the US. Isoray shares (ISR) are listed on the NYSE MKT and all prices are listed in US Dollars. Isoray employs 53 staff and has a trailing 12-month revenue of around 0.00.

Isoray share price

Use our graph to track the performance of ISR stocks over time.

Isoray shares at a glance

• Key figures

Information last updated 2021-04-30.

52-week range	$0.35 - $2.81
50-day moving average	$1.09
200-day moving average	$0.99
Wall St. target price	$2.17
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.08

Buy Isoray shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Isoray stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Isoray, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Isoray financials

Revenue TTM	$9.9 million
Gross profit TTM	$5.1 million
Return on assets TTM	-16.96%
Return on equity TTM	-35.04%
Profit margin	-33.47%
Book value	$0.15
Market capitalisation	$130.6 million

TTM: trailing 12 months

Shorting Isoray shares

There are currently 2.7 million Isoray shares held short by investors – that's known as Isoray's "short interest". This figure is 6.8% down from 2.9 million last month.

There are a few different ways that this level of interest in shorting Isoray shares can be evaluated.

Isoray's "short interest ratio" (SIR)

Isoray's "short interest ratio" (SIR) is the quantity of Isoray shares currently shorted divided by the average quantity of Isoray shares traded daily (recently around 3.6 million). Isoray's SIR currently stands at 0.73. In other words for every 100,000 Isoray shares traded daily on the market, roughly 730 shares are currently held short.

However Isoray's short interest can also be evaluated against the total number of Isoray shares, or, against the total number of tradable Isoray shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Isoray's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Isoray shares in existence, roughly 20 shares are currently held short) or 0.019% of the tradable shares (for every 100,000 tradable Isoray shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Isoray.

Find out more about how you can short Isoray stock.

Isoray share dividends

We're not expecting Isoray to pay a dividend over the next 12 months.

Have Isoray's shares ever split?

Isoray's shares were split on a 1:30 basis on 16 August 2005. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Isoray shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Isoray shares which in turn could have impacted Isoray's share price.

Isoray share price volatility

Over the last 12 months, Isoray's shares have ranged in value from as little as $0.352 up to $2.81. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Isoray's is 1.1125. This would suggest that Isoray's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Isoray overview

Isoray, Inc. , through its subsidiary, IsoRay Medical, Inc. , develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.

Frequently asked questions

• What percentage of Isoray is owned by insiders or institutions?

  Currently 0.776% of Isoray shares are held by insiders and 7.033% by institutions.

• How many people work for Isoray?

  Latest data suggests 53 work at Isoray.

• When does the fiscal year end for Isoray?

  Isoray's fiscal year ends in June.

• Where is Isoray based?

  Isoray's address is: 350 Hills Street, Richland, WA, United States, 99354

• What is Isoray's ISIN number?

  Isoray's international securities identification number is: US46489V1044

• What is Isoray's CUSIP number?

  Isoray's Committee on Uniform Securities Identification Procedures number is: 46489V104